Global Radiopharmaceutical Competitive Landscape Professional Research Report 2025
Research Summary
A radiopharmaceutical is a medicinal compound that contains a radioactive isotope and is used in nuclear medicine for diagnostic or therapeutic purposes. These compounds are designed to target specific organs, tissues, or physiological processes within the body, allowing for the visualization or treatment of specific medical conditions. In diagnostic nuclear medicine procedures, radiopharmaceuticals emit gamma rays that can be detected using specialized imaging equipment, providing valuable information about the structure and function of organs or tissues. In therapeutic applications, the radioactive emissions from the radiopharmaceutical are used to deliver targeted radiation to diseased cells, such as in the treatment of certain types of cancer. Radiopharmaceuticals undergo rigorous testing and regulatory approval processes to ensure their safety and efficacy in medical applications.
According to DIResearch's in-depth investigation and research, the global Radiopharmaceutical market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Radiopharmaceutical include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare, China Isotope & Radiation, Jubilant Pharma, Eli Lilly, Advanced Accelerator Applications, SIEMENS, Dongcheng, Navidea etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Radiopharmaceutical. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Radiopharmaceutical market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Radiopharmaceutical market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Radiopharmaceutical industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Radiopharmaceutical Include:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Radiopharmaceutical Product Segment Include:
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Radiopharmaceutical Product Application Include:
Oncology
Cardiology
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Radiopharmaceutical Industry PESTEL Analysis
Chapter 3: Global Radiopharmaceutical Industry Porter’s Five Forces Analysis
Chapter 4: Global Radiopharmaceutical Major Regional Market Size and Forecast Analysis
Chapter 5: Global Radiopharmaceutical Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Radiopharmaceutical Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Radiopharmaceutical Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Radiopharmaceutical Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Radiopharmaceutical Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Radiopharmaceutical Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Radiopharmaceutical Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Radiopharmaceutical Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Radiopharmaceutical Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Radiopharmaceutical Product by Type
- 1.2.1 Actinium-225
- 1.2.2 Lutetium-177
- 1.2.3 Radium-223
- 1.2.4 Holmium-166
- 1.2.5 Other
- 1.3 Radiopharmaceutical Product by Application
- 1.3.1 Oncology
- 1.3.2 Cardiology
- 1.3.3 Other
- 1.4 Global Radiopharmaceutical Market Size Analysis (2020-2032)
- 1.5 Radiopharmaceutical Market Development Status and Trends
- 1.5.1 Radiopharmaceutical Industry Development Status Analysis
- 1.5.2 Radiopharmaceutical Industry Development Trends Analysis
- 2 Radiopharmaceutical Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Radiopharmaceutical Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Radiopharmaceutical Market Analysis by Regions
- 4.1 Radiopharmaceutical Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Radiopharmaceutical Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Radiopharmaceutical Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Radiopharmaceutical Revenue Forecast by Region (2026-2032)
- 5 Global Radiopharmaceutical Market Size by Type and Application
- 5.1 Global Radiopharmaceutical Market Size by Type (2020-2032)
- 5.2 Global Radiopharmaceutical Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Radiopharmaceutical Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Radiopharmaceutical Market Size by Type
- 6.4 North America Radiopharmaceutical Market Size by Application
- 6.5 North America Radiopharmaceutical Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Radiopharmaceutical Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Radiopharmaceutical Market Size by Type
- 7.4 Europe Radiopharmaceutical Market Size by Application
- 7.5 Europe Radiopharmaceutical Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Radiopharmaceutical Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Radiopharmaceutical Market Size by Type
- 8.4 China Radiopharmaceutical Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Radiopharmaceutical Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Radiopharmaceutical Market Size by Type
- 9.4 APAC (excl. China) Radiopharmaceutical Market Size by Application
- 9.5 APAC (excl. China) Radiopharmaceutical Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Radiopharmaceutical Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Radiopharmaceutical Market Size by Type
- 10.4 Latin America Radiopharmaceutical Market Size by Application
- 10.5 Latin America Radiopharmaceutical Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Radiopharmaceutical Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Radiopharmaceutical Market Size by Type
- 11.4 Middle East & Africa Radiopharmaceutical Market Size by Application
- 11.5 Middle East & Africa Radiopharmaceutical Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Radiopharmaceutical Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Radiopharmaceutical Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Radiopharmaceutical Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Bracco Imaging
- 13.1.1 Bracco Imaging Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Bracco Imaging Radiopharmaceutical Product Portfolio
- 13.1.3 Bracco Imaging Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Bayer
- 13.2.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Bayer Radiopharmaceutical Product Portfolio
- 13.2.3 Bayer Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Mallinckrodt
- 13.3.1 Mallinckrodt Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Mallinckrodt Radiopharmaceutical Product Portfolio
- 13.3.3 Mallinckrodt Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Nordion
- 13.4.1 Nordion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Nordion Radiopharmaceutical Product Portfolio
- 13.4.3 Nordion Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Triad Isotopes
- 13.5.1 Triad Isotopes Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Triad Isotopes Radiopharmaceutical Product Portfolio
- 13.5.3 Triad Isotopes Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Lantheus
- 13.6.1 Lantheus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Lantheus Radiopharmaceutical Product Portfolio
- 13.6.3 Lantheus Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 IBA Group
- 13.7.1 IBA Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 IBA Group Radiopharmaceutical Product Portfolio
- 13.7.3 IBA Group Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 GE Healthcare
- 13.8.1 GE Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 GE Healthcare Radiopharmaceutical Product Portfolio
- 13.8.3 GE Healthcare Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 China Isotope & Radiation
- 13.9.1 China Isotope & Radiation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 China Isotope & Radiation Radiopharmaceutical Product Portfolio
- 13.9.3 China Isotope & Radiation Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Jubilant Pharma
- 13.10.1 Jubilant Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Jubilant Pharma Radiopharmaceutical Product Portfolio
- 13.10.3 Jubilant Pharma Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Eli Lilly
- 13.11.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Eli Lilly Radiopharmaceutical Product Portfolio
- 13.11.3 Eli Lilly Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Advanced Accelerator Applications
- 13.12.1 Advanced Accelerator Applications Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
- 13.12.3 Advanced Accelerator Applications Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 SIEMENS
- 13.13.1 SIEMENS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 SIEMENS Radiopharmaceutical Product Portfolio
- 13.13.3 SIEMENS Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Dongcheng
- 13.14.1 Dongcheng Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Dongcheng Radiopharmaceutical Product Portfolio
- 13.14.3 Dongcheng Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 Navidea
- 13.15.1 Navidea Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Navidea Radiopharmaceutical Product Portfolio
- 13.15.3 Navidea Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Radiopharmaceutical Industry Chain Analysis
- 14.2 Radiopharmaceutical Industry Raw Material and Suppliers Analysis
- 14.2.1 Radiopharmaceutical Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Radiopharmaceutical Typical Downstream Customers
- 14.4 Radiopharmaceutical Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook